AP

BioNTech earnings drop but forecast for vaccine income grows

Nov 6, 2022, 6:14 PM | Updated: Nov 7, 2022, 9:04 am

A view of the logo of the BioNTech biotechnology building where production of the COVID-19 vaccine ...

A view of the logo of the BioNTech biotechnology building where production of the COVID-19 vaccine has started, in Marburg, Germany, Feb. 13, 2021. BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, has reported that third-quarter earnings are close to half what they were a year earlier. The German pharmaceutical company still raised its expectations for vaccine revenue after rolling out updated shots targeting omicron strains in September. (AP Photo/Michael Probst)

(AP Photo/Michael Probst)

BERLIN (AP) — BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, reported that its earnings in the third quarter were close to half what they were a year earlier, but the German pharmaceutical company still raised its expectations for vaccine revenue after rolling out updated shots targeting omicron strains.

The company said Monday that it made net profit of 1.8 billion euros ($1.8 billion) off revenue of 3.5 billion euros ($3.5 billion) in the three months to September, a drop from profit of 3.2 billion euros and revenue of 6.1 billion euros in the same period a year ago.

BioNTech said “the course of the pandemic remains dynamic and led to fluctuations” in earnings. Profit and revenue were largely flat in the first nine months of the year.

“Thanks to our strong execution in the third quarter of 2022, we updated our COVID-19 vaccine revenue guidance for the year 2022 to the upper end of the original range,” said Jens Holstein, CFO of BioNTech. “We started shipments of our Omicron-adapted bivalent vaccines early in September, and we expect to carry on with our deliveries throughout the fourth quarter of 2022.”

Citing those updated vaccines, the company says it expects to make 16 billion to 17 billion euros in revenue from COVID-19 vaccines vs. the previous forecast of 13 billion to 17 billion euros.

The German company splits profits and costs to make and distribute the vaccines with New York-based Pfizer.

Pfizer said last week that its COVID-19 pill treatment Paxlovid helped it balance tumbling international sales for its coronavirus vaccine and top third-quarter expectations.

BioNTech said it’s sold about 300 million doses of the updated COVID-19 vaccines that target omicron strains as of mid-October.

The company says it and Pfizer have delivered a total of about 1.6 billion doses to low- and middle-income countries. Unlike Moderna, Pfizer and BioNTech have not yet agreed to a supply deal for their latest omicron-adapted shots with COVAX, the U.N.-backed program to ship vaccines to poor countries.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

AP

Photo: Homeland Security Secretary Alejandro Mayorkas is sworn-in before the House Committee on Hom...

the MyNorthwest Staff with wire reports

Senate dismisses two articles of impeachment against Homeland Security secretary, ends trial

The Senate dismissed impeachment charges against Homeland Security Secretary Alejandro Mayorkas, as Republicans pushed to remove him.

20 hours ago

idaho gender-affirming care...

Associated Press

Supreme Court allows Idaho to enforce its ban on gender-affirming care for transgender youth

The Supreme Court is allowing Idaho to enforce its ban on gender-affirming care for transgender youth while lawsuits over the law proceed.

2 days ago

Image: Former President Donald Trump speaks to the press in Manhattan state court in New York City ...

Associated Press

Trump’s hush money trial gets underway; 1st day ends without any jurors selected

The historic hush money trial of Donald Trump got underway Monday with the arduous process of selecting a jury to hear the case.

3 days ago

Photo: Israeli Iron Dome air defense system launches to intercept missiles fired from Iran, in cent...

Tia Goldenberg and Josef Federman, The Associated Press

Israel is quiet on next steps against Iran — and on which partners helped shoot down missiles

On Sunday, Israel's leaders credited an international military coalition with helping thwart a direct attack from Iran.

4 days ago

Early phases of Iran's drone attack against Israel. (Photo: Getty Images)...

Associated Press

The Latest | Iran launches its first direct military attack against Israel

Iran launched its first full-scale military attack against Israel on Saturday, sending drones toward Israel.

5 days ago

Early phases of Iran's drone attack against Israel. (Photo: Getty Images)...

Associated Press

BREAKING: White House confirms Iran drone attacks towards Israel

JERUSALEM (AP) — The White House says it will provide unspecified support for Israel’s defense against an ongoing airborne attack from Iran. National Security Council spokesperson Adrienne Watson said in a Saturday statement that “Iran has begun an airborne attack against Israel.” She added: “The United States will stand with the people of Israel and […]

5 days ago

BioNTech earnings drop but forecast for vaccine income grows